Treatment of muscle fatigue
OwnerKieran Clarke, Michaela Scheuermann-Freestone +1inventors
InventorsKieran Clarke, Michaela Scheuermann-Freestone, Andrew Murray
Life of this patent
Estimating the term…
Abstract
The present invention involves the use of a compound that reduces the level of free fatty acids circulating in the plasma of a subject in the manufacture of a medicament for the treatment of prevention of muscle (particularly cardiac or skeletal muscle) impairment or fatigue.
Claims16
A method for preventing and treating muscle fatigue comprising the step of administering to a subject a compound that reduces concentrations of free fatty acids circulating in the plasma of the subject, wherein the muscle is selected from the group consisting of cardiac and skeletal muscle.
A composition for rehydrating a subject, the composition comprising water, a sugar carbohydrate, and a compound that reduces concentrations of free fatty acids circulating in the plasma of the subject, wherein rehydrating the subject is preformed at a period selected from the group consisting of during an exercise period and following an exercise period.
A method for monitoring cardiac muscle function in a subject, the method comprising the steps of:
- i) measuring concentrations of free fatty acids in a blood plasma sample from a fasted subject and ii) quantifying the result with levels of free fatty acids sampled from a control subject.
A device for monitoring cardiac muscle function, the device comprising means for measuring the concentrations of free fatty acids in a plasma sample.
Dependencies are inferred from the claim text.